id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-0811-0004,FDA,FDA-2013-D-0811,Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridium difficile Infection Not Responsive to Standard Therapies,Other,Guidance,2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,,2024-11-12T05:25:14Z,,1,0,09000064815c494a
FDA-2013-D-0811-0003,FDA,FDA-2013-D-0811,Guidance for Industry: Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Availability,Notice,Notice of Availability,2014-02-26T05:00:00Z,2014,2,2014-02-26T05:00:00Z,2014-03-29T03:59:59Z,2014-03-30T02:51:42Z,2014-04095,0,0,09000064815c3a1e